Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcomas

NCT06476704 is registered in ClinicalTrials.gov with Centre Paul Strauss as lead sponsor.

NCT NCT06476704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06476704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcomas
Lead sponsor
Centre Paul Strauss
Phase
Phase 2
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
June 1, 2033
Enrollment
42 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma